Objective and design Work in multiple organs has suggested that toll-like receptor 4 (TLR4) may play a role in insulin resistance. Additional studies have shown a negative role for TLR4 on retinal health. We have previously reported that b-adrenergic receptors can regulate both TLR4 signal transduction, as well as insulin signaling in the retina and in retinal endothelial cells. Thus, we hypothesized that TLR4 would regulate retinal insulin signaling. Materials and methods We used endothelial cell-specific TLR4 knockout mice, as well as TLR4-overexpressing mice for these studies. Methods Western blotting and ELISA analyses were done for investigations of insulin receptor, insulin receptor substrate 1 (IRS-1) serine 307, and Akt phosphorylation, as well as cleaved caspase 3 levels in the mouse retina. Results We found that loss of TLR4 led to increased insulin receptor and Akt phosphorylation, as well as decreased IRS-1 Ser307 levels. In support of these results, TLR4 overexpression decreased insulin signaling and the cleavage of caspase 3.
Introduction
A number of pathologies have been suggested to result from a low-grade chronic inflammation, including diabetic retinopathy, specifically type 2. Retinal damage in type 2 diabetes results from insulin resistance [1] . There is ample evidence that inhibition of various inflammatory pathways can protect the diabetic retina [2] [3] [4] [5] . A key question then arises, is there a common link between insulin resistance and inflammation? One potential link may be toll-like receptor 4 (TLR4) [6] . We have previously reported that badrenergic receptors can regulate TLR4 in the diabetic retina, as well as retinal endothelial cells (REC) and Müller cells [7] . Additionally, we have reported that a b-adrenergic receptor agonist can reduce functional, neuronal, and vascular phenotypes associated with retinopathy with rodents [8] , as well as restore normal insulin signal transduction in cells grown in high glucose [9, 10] .
TLR4 is reported to be both protective and harmful to some systems such as cardiomyocytes, [11] and can mediate a multitude of inflammatory actions in the aorta [12] , arterioles [13] , adipocytes, and macrophages [6] . The key in the response to TLR4 appears to be cell and disease specific. In hepatocytes, loss of TLR4 led to improved glucose tolerance, insulin sensitivity, and reduced hepatic stenosis, despite a high-fat diet in mice [14] . In the same study, the authors found that loss of TLR4 in myeloid cells had little effect on insulin sensitivity [14] . In human aortic endothelial cells, TLR4 caused ER stress [13] , when TLR4 was activated by saturated fatty acids. If TLR4 was eliminated, the arterioles were protected against a high-fat diet [13] . Similarly, loss of TLR4 was protective to the thoracic aorta, through decreased NFjB, ICAM1, and IL-6, with increased levels of Akt and eNOS [12] . Work has also suggested that one pathway by which TLR4 is detrimental is through activation of resistin, an adipokine. TLR4 knockout mice have reduced resistin, which results in cardiovascular damage [15] . Recent work also points to a role for TLR4 in neuroinflammation in the CNS [16] .
While much has been done to explore TLR4 in the cardiovascular and adipocyte systems, this study focused on the role of TLR4 in the retina. Work in TLR4 knockout mice on a high-fat diet showed that loss of TLR4 decreased insulin resistance, obesity and improved glucose tolerance. This was associated with decreased phosphorylation of NFjB, IL-6, and other inflammatory pathways [17] . Furthermore, work in the streptozotocininduced diabetic rat showed that diabetes increased TLR4 signaling, leading to increased levels of key inflammatory mediators [18] . Taken together, there is literature to demonstrate localization and activation of TLR4 signaling in the retina, leading to retinopathy-associated complications.
To further the work in the previous literature, we used endothelial-cell-specific conditional knockout mice for TLR4 and TLR4-overexpressing mice with normal glucose levels to investigate whether TLR4 regulates retinal insulin receptor signaling.
Materials and methods

Mice
All animal procedures meet the Association for Research in Vision and Ophthalmology requirements and were approved by the Institutional Animal Care and Use Committee of Wayne State University and conform to NIH guidelines.
Endothelial-cell-specific TLR4 knockout mice
The TLR4 floxed mice (B6(Cg)-Tlr4 tm1.1Karp /J mice) and B6 FVB-Tg (cdh5-cre)7Mlia/J Cre mice were purchased from Jackson Laboratories. After two generations, TLR4 floxed mice were bred with cdh5-Cre mice to generate conditional knockout mice in which TLR4 is eliminated in vascular endothelial cells. Around 3 months of age, TLR4 floxed and TLR4 Cre-Lox mice were used for experiments.
TLR4-overexpressing mice
TLR4-overexpressing mice were a kind gift from Dr. Danielle Malo, McGill University [19] . A pathogen-free line of 6xTLR4 (Tg390) carrying six copies of the TLR4 gene was established in C57BL/10ScNJ background mice. Wild-type controls used were C57BL/10SnJ mice. Mice were genotyped at approximately 2-3 weeks of age. At 3 months, TLR4-overexpression mice and corresponding wild-type mice were used for experiments.
Genotyping
Genomic DNA was extracted from ear punch samples from 2-to 3-week-old mice. Ear punches were digested with one-step tail DNA extraction buffer (100 mM Tris, 5 mM EDTA, 200 mM NaCl, 1% Triton) plus proteinase K (10 mg/ml) at 55°C overnight, followed by heat inactivation at 85°C for 45 min.
Sequences of primer pairs used to screen the TLR4 cdh5-cre-lox conditional knockout mice were as follows: TLR4 floxed: 5 0 ? 3 0 mutant forward: TGA CCA CCC ATA TTG CCT ATA C; reverse: TGA TGG TGT GAG CAG GAG AG; Cdh5-cre forward: AGG CAG CTC ACA AAG GAA CAA T; reverse: TCG TTG CAT CGA CCG GTA A; Cdh5-cre internal positive control forward: CTA GGC CAC AGA ATT GAA AGA TCT; reverse: GTA GGT GGA AAT TCT AGC ATC ATC C. The standard PCR was done using KAPA2G HotStart Genotyping PCR Mix (KK5621, KAPA Biosystems). The PCR was performed with following temperatures and times: denature: 95°C 3 min, 35 cycles at 95°C, 15 s, 60°C 15 s, 72°C sec/kb, with final extension at 72°C for 1 min.
For TLR4-overexpression mice: forward primer: 5 0 ? 3 0 AGA AGA GCT GCA GCA CCT GGA TTT; reverse primer 5 0 ? 3 0 GAT GAA ATT GGA ATG AAG ACC TCT CA. PCR was performed with following temperatures and times: 94°C 3 min, 35 cycles at 94°C, 30 s, 50°C 30 s 72°C 30 s with the final extension at 72°C for 10 min.
Western blotting
Whole retinal lysates from mice were collected into lysis buffer containing protease and phosphatase inhibitors. Equal amounts of protein were separated onto a pre-cast tris-glycine gel (Invitrogen, Carlsbad, CA, USA), and blotted onto nitrocellulose membrane. After blocking in TBST (10 mM Tris-HCl buffer, pH 8.0, 150 mM NaCl, 0.1% Tween 20) and 5% (w/v) BSA, the membranes were treated with TLR4 (Abcam, Cambridge, MA, USA), Akt, phosphorylated Akt (Ser473), insulin receptor, phosphorylated insulin receptor (Tyr 1150/1151), insulin receptor substrate 1, phosphorylated insulin receptor substrate 1 [(Ser 307), Cell Signaling Technology, Danvers, MA, USA] and beta-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) primary antibodies followed by incubation with secondary antibodies labeled with horseradish peroxidase. Antigen-antibody complexes were detected by chemiluminescence reagent kit (Thermo Scientific, Pittsburgh, PA, USA) and data were acquired using an Azure C500 (Azure Biosystems, Dublin, CA, USA). Western blot data were assessed using Image Studio Lite software.
ELISA
A cleaved caspase 3 ELISA was done according to the manufacturer's instructions (Cell Signaling Technology, Danvers, MA, USA) with equal protein loaded to allow for comparison using the optical density measurement (O.D).
Statistics
One-way ANOVA with Student-Newman-Keuls post hoc test was used. P \ 0.05 was considered statistically significant. A representative western blot is shown where appropriate.
Results
Genotyping and protein analyses confirm TLR4 conditional knockout mice and TLR4-overexpressing mice Figure 1a shows the genotyping results for the TLR4 floxed and TLR4/cdh5-Cre-Lox mice to confirm knockdown of TLR4. Figure 1b shows that TLR4 protein levels are reduced in the TLR4 Cre-Lox mice. Figure 1c shows overexpression of TLR4 in the TLR4 OE mice vs. the C57BL/10SnJ wild-type controls. Overexpression of TLR4 protein levels were noted in the TLR4 OE mice when compared to littermates (Fig. 1d) .
Overexpression of TLR4 reduces insulin receptor phosphorylation, leading to increased IRS-1
Ser307 phosphorylation
We have previously reported that TNFa decreased insulin receptor activation, which occurred concurrently with increased IRS1 Ser307 phosphorylation [9] . Since we showed that TLR4 increased TNFa levels in the mice, we wanted to determine if TLR4 could drive insulin resistance in the mouse retina. Figure 2a shows that loss of TLR4 in the vascular cells of the retina leads to increased insulin receptor phosphorylation. TLR4 overexpression significantly decreased insulin receptor phosphorylation (Fig. 2b) . In contrast to insulin receptor, loss of TLR4 decreased IRS-1 Ser307 phosphorylation (Fig. 2c) , which would suggest reduced insulin resistance. Overexpression of TLR4 increased IRS-1 Ser307 phosphorylation (Fig. 2d) .
TLR4 regulates Akt phosphorylation to control apoptosis in the retina
Increased IRS-1 Ser307 often leads to decreased Akt phosphorylation and increased apoptosis [20] . Figure 3a shows that loss of TLR4 increased Akt phosphorylation, while TLR4 overexpression reduced Akt phosphorylation (Fig. 3b) . Since Akt can decrease the cleavage of caspase 3 in REC [9] , Fig. 3c shows that loss of TLR4 decreased cleaved caspase 3 levels. Overexpression of TLR4 increased cleavage of caspase 3. These data suggest that TLR4 is involved in the insulin signal transduction pathway in the mouse retina.
Discussion
Insulin insensitivity is a key component of type 2 diabetes. More recently, the role of a low-grade inflammation has become of increasing interest, as it may relate to insulin responsiveness [6] . Furthermore, data suggest that insulin responsiveness is organ specific [14] . Work in hepatocytes suggested that loss of TLR4 was strongly associated with improved glucose tolerance and insulin sensitivity, despite maintenance of a high-fat diet [14] . Similarly, TLR4 regulated insulin receptor signaling in muscle following systemic lipid infusion [6] . Work in the aorta has shown that palmitate blocked insulin signal transduction, which was blocked in TLR4 knockout mice [12] . Using interferon regulatory factor 3 (IRF3) knockout mice, work showed that these mice are protected against obesity through decreased TLR4 signaling [21] . In contrast to work on the aorta and insulin-responsive organs, a study did show that TLR4 is protective to cardiomyocytes, producing decreased apoptosis through iNOS and MyD88 [11] . But, work in these same cells showed that TLR4/MyD88 can induce insulin resistance if retinal-binding protein 4 (RBP4) levels are high [22] .
While there is much literature in known insulin-sensitive organs, such as adipocytes and liver, less work has focused on the retina. Using systemic TLR4 knockout mice, work has shown that loss of TLR4 leads to increased neuronal thickness of the retina in response to LPS [23] . TLR4 knockout mice on a high-fat diet had less retinal degeneration and DNA damage than their wild-type littermates on the same diet [17] , likely through reduced macrophage and microglial activation. While there is work to show that systemic loss of TLR4 regulates insulin-resistant proteins to increase apoptosis in the mouse retina 995 TLR4 in mice led to retinal protection, less was known about TLR4 regulation of insulin signaling. In this study, we used endothelial-cell-specific knockout mice and TLR4-overexpressing mice (Fig. 1) to show that TLR4 has a significant response on insulin signal transduction and retinal cell apoptosis. Loss of TLR4 in endothelial cells led to improved insulin receptor phosphorylation and Akt phosphorylation, with reduced IRS-1 Ser307 and TNFa levels. In contrast, overexpression of TLR4 increased cleaved caspase 3 levels in retinal lysates, likely due to the increased TNFa and IRS-1 Ser307 phosphorylation. Thus, our data strongly support work in other organs that TLR4 can reduce insulin signaling. These data agree with other studies on IGFBP-3 and badrenergic receptors, which showed altered insulin signaling, despite normal glucose levels [24, 25] . Further studies on insulin signal transduction and TLR4 will be done once these mice are made diabetic.
Conclusions
In conclusion, the data support that TLR4 is involved in the insulin signaling pathway in the retina. In endothelial-cellspecific TLR4 knockout mice, insulin receptor, and Akt phosphorylation were significantly increased, while IRS-1 Ser307 phosphorylation was decreased. In support of these findings, TLR4 overexpression led to decreased insulin receptor signaling and increased cleavage of caspase 3. These data suggest that TLR4 regulates insulin resistance proteins in the retina.
